These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15225747)

  • 1. Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1alpha,25(OH)2D3 and Gemini: purification, crystallization and preliminary X-ray diffraction analysis.
    Ciesielski F; Rochel N; Mitschler A; Kouzmenko A; Moras D
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):55-9. PubMed ID: 15225747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional model of the ligand binding domain of the nuclear receptor for 1alpha,25-dihydroxy-vitamin D(3).
    Norman AW; Adams D; Collins ED; Okamura WH; Fletterick RJ
    J Cell Biochem; 1999 Sep; 74(3):323-33. PubMed ID: 10412035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
    Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-mediated conformational changes of the VDR are required for gene transactivation.
    Carlberg C
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):227-32. PubMed ID: 15225776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
    Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
    Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of the selective activity of vitamin D analogues.
    Carlberg C
    J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.
    Mizwicki MT; Bishop JE; Norman AW
    Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
    J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.
    Ciesielski F; Rochel N; Moras D
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):235-42. PubMed ID: 17218092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.
    Rochel N; Hourai S; Pérez-García X; Rumbo A; Mourino A; Moras D
    Arch Biochem Biophys; 2007 Apr; 460(2):172-6. PubMed ID: 17346665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.
    Peräkylä M; Molnár F; Carlberg C
    Chem Biol; 2004 Aug; 11(8):1147-56. PubMed ID: 15324816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function relationships of vitamin D including ligand recognition by the vitamin D receptor.
    Yamada S; Shimizu M; Yamamoto K
    Med Res Rev; 2003 Jan; 23(1):89-115. PubMed ID: 12424754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and preliminary crystallographic characterization of the vitamin D sterol- and actin-binding by human vitamin D-binding protein.
    Swamy N; Head JF; Weitz D; Ray R
    Arch Biochem Biophys; 2002 Jun; 402(1):14-23. PubMed ID: 12051678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain.
    Yamamoto K; Masuno H; Choi M; Nakashima K; Taga T; Ooizumi H; Umesono K; Sicinska W; VanHooke J; DeLuca HF; Yamada S
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1467-72. PubMed ID: 10677485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of residues 143 and 278 of the human nuclear Vitamin D receptor in the full-length and Delta165-215 deletion mutant.
    Acevedo A; Stoynova L; Davis K; Solórzano R; Collins ED
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):83-7. PubMed ID: 15225751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
    Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
    J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and X-ray crystallographic study of new nonsecosteroidal vitamin D receptor ligands.
    Demizu Y; Takahashi T; Kaneko F; Sato Y; Okuda H; Ochiai E; Horie K; Takagi K; Kakuda S; Takimoto-Kamimura M; Kurihara M
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6104-7. PubMed ID: 21889334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of the putative helices 4 and 5 of human vitamin D(3) receptor for conformation and ligand binding.
    Väisänen S; Duchier C; Rouvinen J; Mäenpää PH
    Biochem Biophys Res Commun; 1999 Oct; 264(2):478-82. PubMed ID: 10529388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling, affinity labeling, and site-directed mutagenesis define the key points of interaction between the ligand-binding domain of the vitamin D nuclear receptor and 1 alpha,25-dihydroxyvitamin D3.
    Swamy N; Xu W; Paz N; Hsieh JC; Haussler MR; Maalouf GJ; Mohr SC; Ray R
    Biochemistry; 2000 Oct; 39(40):12162-71. PubMed ID: 11015194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.